Introducing the second edition of CHAI s HIV Mid Year Market Memo an informational brief that covers the latest trends in the HIV space in low and middle income countries …
Background: Most of the world's population is not covered by cancer surveillance systems or vital registration, and worldwide/UN-regional cancer incidence is estimated using a variety of methods. Quantifying the cancer …
MEDLINE Abstract: Human immunodeficiency virus (HIV) is a global health problem. It renders the central nervous system susceptible to infectious and noninfectious diseases. HIV-positive individuals may present to neurosurgical services …
Pulmonary tuberculosis disease (TB), caused by infection with Mycobacterium tuberculosis (Mtb), remains a major public health threat globally, with a high burden in Sub-Saharan Africa. In this study, we explored …
In Uganda, the social expectation that women should bear children competes with HIV clinic expectation that HIV-positive women should bear few or none. This contradiction undergirds this thesis, which examines …
Background and methodology This study determined the unmet need for family planning among HIV-positive and HIV-negative individuals living in western Uganda. Semi-structured interviews were conducted with individuals who were randomly …
Conducting e-readiness assessment for an e-Health system before implementation may save time, money and energy. A mere rollout of e-Health system contributes less to their successful implementation. This study aims …
This editorial provides an overview of the papers presented in the issue British Journal of Guidance & Counselling. The practice of counselling and guidance in Africa may not be very …
The article discusses the 25-year existence of the Tropical Health Education Trust (THET) whose primary goal is to build global health partnerships between Great Britain and resource-poor countries. Topics covered …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …